Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 4/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17724493 | 0.87 | CYP2D6 (0.46) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL3940548 | 0.87 | CYP2D6 (0.46) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL22159629 | 0.87 | SRC (0.46) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL24327749 | 0.87 | CYP2D6 (0.46) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL11404609 | 0.83 | SRC (0.52) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL974061 | 0.83 | SRC (0.52) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL29123687 | 0.82 | LMNA (0.45) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL103235 | 0.81 | ALDH1A1 (0.54) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL248434 | 0.81 | SRC (0.50) | SRCCYP2D6LMNAMAPK1ALDH1A1 | |
| SCHEMBL155984 | 0.81 | ALDH1A1 (0.54) | SRCCYP2D6LMNAMAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11780872-B2 | Oligosaccharide analytical standards | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2023-10-10 | — | — | US | claimed |
| US-20210171562-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-10 | — | — | US | claimed |
| US-12152053-B2 | Oligosaccharide analytical standards | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-11-26 | — | — | US | disclosed |
| US-20240199675-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2024-06-20 | — | — | US | disclosed |
| US-11780872-B2 | Oligosaccharide analytical standards | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-20210171562-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-10 | — | — | US | disclosed |
| US-5932619-A | PROTECTIVE AGENT IS A DIMER OF MANDELIC ACID OR A DIMER OF SUBSTITUTED MANDELIC ACID. | RUSH-PRESBYTERIAN, ST. LUKE'S MEDICAL CENTER (US) | 1999-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12152053-B2 | Oligosaccharide analytical standards | OSTC, FUT5, FUT6 | SRC 4260/4885CYP2D6 2093/4885LMNA 2658/4885 |
| US-11780872-B2 | Oligosaccharide analytical standards | OSTC, FUT5, FUT6 | SRC 4260/4885CYP2D6 2093/4885LMNA 2658/4885 |
| US-20240199675-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | OSTC, FUT5, FUT6 | SRC 4260/4885CYP2D6 2093/4885LMNA 2658/4885 |
| US-20210171562-A1 | OLIGOSACCHARIDE ANALYTICAL STANDARDS | OSTC, FUT5, FUT6 | SRC 4260/4885CYP2D6 2093/4885LMNA 2658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.